Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy
- PMID: 20105436
- PMCID: PMC2891875
- DOI: 10.1016/j.steroids.2010.01.011
Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy
Abstract
Male sex is a risk factor for development and progression of diabetic nephropathy; however, the relationship between sex hormone levels and diabetic nephropathy in type 1 diabetic men is unknown. This was a prospective follow-up study as part of the nationwide Finnish Diabetic Nephropathy (FinnDiane) Study; 297 patients were followed for 5.9+/-1.5 years. Serum total testosterone (Tt) and estradiol (Te), calculated free testosterone (cFt) and estradiol (cFe) and sex hormone binding globulin were measured at baseline and correlated with urinary albumin excretion rate, estimated glomerular filtration rate and markers of metabolic syndrome. Diabetes without renal disease was associated with decreased Tt (p<0.001), Te (p<0.001) and cFt (p=0.001) levels compared with healthy non-diabetic men. With progression of renal disease from micro- to macroalbuminuria, this decrease in serum Tt was even more pronounced. Cox regression showed that cFt and cFe were independent predictors of the progression from macroalbuminuria to end-stage renal disease. Our study shows that men with type 1 diabetes exhibit dysregulated sex hormone levels, which is most pronounced in men with progressive renal disease, suggesting that sex hormones may play a role in the pathogenesis of diabetic nephropathy associated with type 1 diabetes.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Sex hormone levels are not associated with progression of renal disease in male patients with T2DM.Diabetes Metab. 2017 Apr;43(2):140-145. doi: 10.1016/j.diabet.2016.05.012. Epub 2016 Jun 22. Diabetes Metab. 2017. PMID: 27344412
-
Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.Diabetes Care. 2008 Jun;31(6):1165-9. doi: 10.2337/dc07-2306. Epub 2008 Mar 17. Diabetes Care. 2008. PMID: 18346990
-
Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.Diabetes Obes Metab. 2018 Dec;20(12):2759-2767. doi: 10.1111/dom.13456. Epub 2018 Aug 7. Diabetes Obes Metab. 2018. PMID: 29962015
-
Estrogens and the diabetic kidney.Gend Med. 2008;5 Suppl A(Suppl A):S103-13. doi: 10.1016/j.genm.2008.03.010. Gend Med. 2008. PMID: 18395675 Free PMC article. Review.
-
Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes.Diabet Med. 2025 Feb;42(2):e15431. doi: 10.1111/dme.15431. Epub 2024 Sep 5. Diabet Med. 2025. PMID: 39235140 Free PMC article. Review.
Cited by
-
Effects of diabetes-induced hyperglycemia on epigenetic modifications and DNA packaging and methylation during spermatogenesis; A narrative review.Iran J Basic Med Sci. 2024;27(1):3-11. doi: 10.22038/IJBMS.2023.69604.15173. Iran J Basic Med Sci. 2024. PMID: 38164482 Free PMC article. Review.
-
A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy.Evid Based Complement Alternat Med. 2018 Nov 1;2018:7043402. doi: 10.1155/2018/7043402. eCollection 2018. Evid Based Complement Alternat Med. 2018. PMID: 30519269 Free PMC article.
-
Impact of Sarcopenia, Dynapenia, and Obesity on Muscle Strength and Quality in Chronic Kidney Disease Patients: A Sex-Specific Study.Healthcare (Basel). 2025 Jul 7;13(13):1621. doi: 10.3390/healthcare13131621. Healthcare (Basel). 2025. PMID: 40648645 Free PMC article.
-
Podocytopathy in diabetes: a metabolic and endocrine disorder.Am J Kidney Dis. 2011 Oct;58(4):637-46. doi: 10.1053/j.ajkd.2011.03.035. Epub 2011 Jun 29. Am J Kidney Dis. 2011. PMID: 21719174 Free PMC article. Review.
-
Research on the potential mechanism of Chuanxiong Rhizoma on treating Diabetic Nephropathy based on network pharmacology.Int J Med Sci. 2020 Aug 21;17(15):2240-2247. doi: 10.7150/ijms.47555. eCollection 2020. Int J Med Sci. 2020. PMID: 32922187 Free PMC article.
References
-
- Neugarten J. Gender and the progression of renal disease. J Am Soc Nephrol. 2002;13:2807–2809. - PubMed
-
- Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis. 1995;25:515–533. - PubMed
-
- Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R, Rigamonti G, Spezia R, Crepaldi G. Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study. Diabetologia. 1994;37:1015–1024. - PubMed
-
- Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH. Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl. 1999;71:S101–S105. - PubMed
-
- Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW. Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis. 1995;25:836–844. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical